-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QsTKrm0DcXdZnBN3X97VQUjarQrkenILn0sUhx0gr95DigONuCvIsrnNt4t5apfd TUp1Z7e2cADr8vK7xwh4DQ== 0000716054-09-000018.txt : 20090708 0000716054-09-000018.hdr.sgml : 20090708 20090708132416 ACCESSION NUMBER: 0000716054-09-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090706 FILED AS OF DATE: 20090708 DATE AS OF CHANGE: 20090708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KRANZLER JAY D CENTRAL INDEX KEY: 0001055666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12943 FILM NUMBER: 09934712 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYPRESS BIOSCIENCE INC CENTRAL INDEX KEY: 0000716054 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222389839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE,SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584522323 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE,SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: IMRE CORP DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-07-06 0000716054 CYPRESS BIOSCIENCE INC CYPB 0001055666 KRANZLER JAY D 4350 EXECUTIVE DRIVE SUITE 214 SAN DIEGO CA 92121 1 1 0 0 CEO Common Stock 2009-07-06 4 M 0 75000 2.51 A 171742 I By Trust Common Stock 2009-07-06 4 S 0 75000 8.7015 D 96742 I By Trust Common Stock 625 D Stock Options (right to buy) 2.51 2009-07-06 4 M 0 75000 0 D 2007-03-27 2013-03-27 Common Stock 75000 112874 D The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2009. The weighted average sale price for the transaction reported was $8.7015, the range of prices were between $8.56 and $8.852. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. The shares subject to the option were fully vested as of March 27, 2007. /s/ Sabrina Johnson Attorney-in-Fact 2009-07-08 -----END PRIVACY-ENHANCED MESSAGE-----